1. Home
  2. COCO vs EWTX Comparison

COCO vs EWTX Comparison

Compare COCO & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Vita Coco Company Inc.

COCO

The Vita Coco Company Inc.

N/A

Current Price

$65.97

Market Cap

4.2B

ML Signal

N/A

Logo Edgewise Therapeutics Inc.

EWTX

Edgewise Therapeutics Inc.

N/A

Current Price

$40.84

Market Cap

3.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
COCO
EWTX
Founded
2004
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.7B
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
COCO
EWTX
Price
$65.97
$40.84
Analyst Decision
Buy
Buy
Analyst Count
9
6
Target Price
$57.75
$39.00
AVG Volume (30 Days)
1.3M
1.0M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
26.60
N/A
EPS
1.32
N/A
Revenue
N/A
N/A
Revenue This Year
$16.12
N/A
Revenue Next Year
$11.40
N/A
P/E Ratio
$49.98
N/A
Revenue Growth
N/A
N/A
52 Week Low
$31.82
$12.31
52 Week High
$85.83
$48.40

Technical Indicators

Market Signals
Indicator
COCO
EWTX
Relative Strength Index (RSI) 37.21 55.70
Support Level $65.11 $29.03
Resistance Level $69.59 $43.93
Average True Range (ATR) 3.87 2.49
MACD -0.58 -0.31
Stochastic Oscillator 4.48 42.60

Price Performance

Historical Comparison
COCO
EWTX

About COCO The Vita Coco Company Inc.

The Vita Coco Co Inc is a plant-based functional hydration platform. Its products include Vita Coco Coconut Water, Private Label including coconut water and oil, and Other including Runa, Ever & Ever, and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, such as Vita Coco Sparkling, coconut milk products, and others. The company has two segments: The Americas segment which comprises of operations in the U.S. and Canada; and The International segment that comprises of operations in Europe, the Middle East, Africa and the Asia Pacific regions. The Americas segment derives maximum revenue. Geographical presence of the company is in United States, United Kingdom and All other countries.

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.

Share on Social Networks: